The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
The European Brain Council is a non-profit organization dedicated to promoting brain research and improving the lives of the estimated 179 million Europeans living with brain conditions. Here, they discuss efforts aimed at enhancing care and raising awareness about brain health in Europe.
Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease
From the...
Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to...
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography
The Murray and Nadel’s...
Rosienne Farrugia from the University of Malta explores the role of high throughput sequencing (HTS) in rare and complex diseases, including the move towards...
As part of their partnership, Rhineland-Palatinate region of Germany and Rwanda foster the exchange of knowledge in hospital management, medical professions and psychiatric care...
Mental Health Europe and the University of Kent-Tizard Centre have launched a new report which has revealed the flaws and human rights challenges in...
Jonathan Evans, communications manager at the Association of British Healthcare Industries explores the broad and diverse MedTech sector as it stands today
The Medical Technology...
David H Peyton. Ph.D., Professor of Chemistry at Portland State University explores the progress being made on malaria in the world today
The annual report...
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry
Cecilia Van Cauwenberghe from Frost & Sullivan explores advancing opportunities for personalised treatment of chronic kidney disease (CKD) and research into membranous nephropathy (MN)
According...
Prof. Anna C. Whittaker from University of Birmingham’s School of Sport, Exercise & Rehabilitation Sciences looks at the need for ageing research in Europe
Current...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are...
Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to...
